
Sign up to save your podcasts
Or


Guest: Dr. Sasha High, internal medicine and obesity physician
Ozempic has been all over the news and social media as it has been hailed as the miracle drug for weight loss. As it is a trend among A-list celebrities, it's also found itself surrounded by controversy. Experts say Ozempic is a medicine, not a TikTok trend and needs to be taken with the advice of your doctor. Last year, Ozempic hype and reported off-label use led to a shortage of the drug in certain regions for people who needed it, including diabetics. It isn't all black and white — diabetes and obesity are often interrelated — and this drug and others like it could be a game changer for those struggling with both. That's around seven per cent of the population in Canada.
This episode was produced by Paulo Marques, Julia De Laurentiis Johnston and Saba Eitizaz.
By Toronto Star4.4
1616 ratings
Guest: Dr. Sasha High, internal medicine and obesity physician
Ozempic has been all over the news and social media as it has been hailed as the miracle drug for weight loss. As it is a trend among A-list celebrities, it's also found itself surrounded by controversy. Experts say Ozempic is a medicine, not a TikTok trend and needs to be taken with the advice of your doctor. Last year, Ozempic hype and reported off-label use led to a shortage of the drug in certain regions for people who needed it, including diabetics. It isn't all black and white — diabetes and obesity are often interrelated — and this drug and others like it could be a game changer for those struggling with both. That's around seven per cent of the population in Canada.
This episode was produced by Paulo Marques, Julia De Laurentiis Johnston and Saba Eitizaz.

377 Listeners

234 Listeners

207 Listeners

218 Listeners

72 Listeners

68 Listeners

109 Listeners

13 Listeners

92 Listeners

430 Listeners

30 Listeners

227 Listeners

98 Listeners

58 Listeners

108 Listeners

1 Listeners

3 Listeners

23 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

48 Listeners